CATEGORIES

Prof. Christian Wolfrum to join NTU as Deputy President and Provost
BioSpectrum Asia

Prof. Christian Wolfrum to join NTU as Deputy President and Provost

Nanyang Technological University, Singapore (NTU Singapore) has announced that Professor Christian Wolfrum, an eminent biomedical scientist, will be joining the University as the next Deputy President and Provost.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Japan suggests addition of PVA into drugs for strong antitumour activity
BioSpectrum Asia

Japan suggests addition of PVA into drugs for strong antitumour activity

Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue.

time-read
1 min  |
BioSpectrum Asia Feb 2025
"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"
BioSpectrum Asia

"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"

2024 saw Japanese medtech firm Olympus receiving approval for the company's first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”.

time-read
5 mins  |
BioSpectrum Asia Feb 2025
BeiGene names Giancarlo Benelli as Head of Europe biz
BioSpectrum Asia

BeiGene names Giancarlo Benelli as Head of Europe biz

BeiGene, a Hong Kong-headquartered oncology company that intends to change its name to BeOne Medicines Ltd., has announced the appointment of Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Korea develops innovative injectable adhesive hydrogel for bone regeneration
BioSpectrum Asia

Korea develops innovative injectable adhesive hydrogel for bone regeneration

A research team from South Korea-based Pohang University of Science and Technology or POSTECH's Department of Chemical Engineering and Graduate School of Convergence Science and Technology, along with the Department of Chemical Engineering, has developed an innovative injectable adhesive hydrogel for bone regeneration.

time-read
1 min  |
BioSpectrum Asia Feb 2025
When Clinical Trials Suffer From 'Complicated' Interactions
BioSpectrum Asia

When Clinical Trials Suffer From 'Complicated' Interactions

Diversity in culture, language, and data gathering methods will further increase the difficulty of clinical trials as they become more international, particularly with the growing number of sites being employed across China, Japan, South Korea, and India.

time-read
5 mins  |
BioSpectrum Asia Feb 2025
Dr Krishna M Ella receives prestigious INSA India fellowship
BioSpectrum Asia

Dr Krishna M Ella receives prestigious INSA India fellowship

Dr Krishna Ella, a distinguished scientist, co-founder and Executive Chairman of Bharat Biotech International, has been recognised with the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, for his contributions to new knowledge, discoveries, development of new vaccine technologies, noteworthy improvement in existing technologies.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Bruker launches infrared imaging microscope for pharma and life science research
BioSpectrum Asia

Bruker launches infrared imaging microscope for pharma and life science research

US-based Bruker Corporation has announced the launch of the LUMOS II ILIM, a quantum cascade laser (QCL) based infrared (IR) imaging microscope.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities
BioSpectrum Asia

Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities

Qiagen has announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analysed from a single biological sample.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers
BioSpectrum Asia

Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers

US-based Repligen Corporation has announced the commercial launch of its CTech SoloVPE PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Bio-Techne and Waters ink comarketing agreement for biotherapeutic characterisation
BioSpectrum Asia

Bio-Techne and Waters ink comarketing agreement for biotherapeutic characterisation

American life sciences company Bio-Techne Corporation, a leader in automated platforms for biotherapeutic characterization, has announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Singapore appoints Tan Chong Meng as Chairman of National University Health System
BioSpectrum Asia

Singapore appoints Tan Chong Meng as Chairman of National University Health System

The Minister for Health has appointed Tan Chong Meng as the Chairman of the Board of the National University Health System (NUHS) from January 1, 2025 to December 31, 2027.

time-read
1 min  |
BioSpectrum Asia Feb 2025
"There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility"
BioSpectrum Asia

"There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility"

Docquity, headquartered in Singapore, is Southeast Asia's largest professional network for verified healthcare professionals (HCPs), connecting over 410,000 doctors across the region.

time-read
4 mins  |
BioSpectrum Asia Feb 2025
Singapore boosts chemotherapy uptake in breast cancer treatment with localised magnetic fields
BioSpectrum Asia

Singapore boosts chemotherapy uptake in breast cancer treatment with localised magnetic fields

Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects.

time-read
1 min  |
BioSpectrum Asia Feb 2025
APAC takes Centre stage in Al-Driven Drug Discovery
BioSpectrum Asia

APAC takes Centre stage in Al-Driven Drug Discovery

The Asia-Pacific (APAC) region is rapidly emerging as a leader in Al-driven drug discovery, fuelled by robust research ecosystems and strong industry collaboration.

time-read
10+ mins  |
BioSpectrum Asia Feb 2025
UK declares biggest investment of £126 M into hospices
BioSpectrum Asia

UK declares biggest investment of £126 M into hospices

The biggest investment in a generation for hospices has been announced by the UK government, ensuring that hospices can continue to deliver the highest quality end-of-life care possible for their patients, families, and loved ones.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Universities in China & Pakistan ink MoU for advanced research in health sciences
BioSpectrum Asia

Universities in China & Pakistan ink MoU for advanced research in health sciences

The School of Medicine, Shihezi University, Xinjiang, China, and the Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan, have signed a landmark Memorandum of Understanding (MoU) to foster collaboration in cutting-edge scientific research and academic exchange.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Australia manufactures 3D printed scaffolding to rebuild jaw bones
BioSpectrum Asia

Australia manufactures 3D printed scaffolding to rebuild jaw bones

Clinicians have successfully used custom-made 3D printed bone scaffolds, printed on-site at The University of Queensland (UQ) in Australia, to rebuild part of a man's jawbone.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Abu Dhabi announces AED 19 M in grants through Healthcare Research and Innovation Fund
BioSpectrum Asia

Abu Dhabi announces AED 19 M in grants through Healthcare Research and Innovation Fund

The Department of Health - Abu Dhabi (DOH), the regulator of the healthcare sector in the Emirate, in partnership with the Authority of Social Contribution - Ma'an, the Abu Dhabi Government's dedicated platform that connects the government, private sector, and wider community to address key social priorities, has awarded over AED 19 million in grants through the Healthcare Research and Innovation Fund.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Gavi facilitates donations of mpox vaccine doses, with first delivery to Nigeria
BioSpectrum Asia

Gavi facilitates donations of mpox vaccine doses, with first delivery to Nigeria

A shipment of 11,200 doses, donated by the United States of America and facilitated by Gavi, the Vaccine Alliance, were recently shipped to Abuja, Nigeria.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Fujirebio and Eisai to establish diagnostic technologies for neurodegenerative diseases
BioSpectrum Asia

Fujirebio and Eisai to establish diagnostic technologies for neurodegenerative diseases

Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a Memorandum of Understanding (MoU) for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Japan gives nod to first subcutaneous immunoglobulin (fSCIG) therapy
BioSpectrum Asia

Japan gives nod to first subcutaneous immunoglobulin (fSCIG) therapy

Japanese Ministry of Health, Labour and Welfare has approved the use of Takeda's HYQVIA [Immune Globulin Infusion 10 percent (Human) with Recombinant Human Hyaluronidase] in patients with agammaglobulinemia or hypogammaglobulinemia, disorders characterized by very low or absent levels of antibodies and an increased risk of serious recurring infection caused by primary immunodeficiency (PID) or secondary immunodeficiency (SID).

time-read
1 min  |
BioSpectrum Asia Feb 2025
UAE nears completion of National Health Survey
BioSpectrum Asia

UAE nears completion of National Health Survey

The Ministry of Health and Prevention (MOHAP) in the United Arab Emirates (UAE) has announced a significant milestone in its national surveys project, with 95 percent completion rate for the National Health Survey and 78 percent for the National Nutrition Survey, marking a significant step toward building a robust health database.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Julia Wang steps in as Executive Vice President and CFO at Labcorp
BioSpectrum Asia

Julia Wang steps in as Executive Vice President and CFO at Labcorp

Labcorp, a global leader of innovative and comprehensive laboratory services, has announced that Executive Vice President and Chief Financial Officer (CFO) Glenn Eisenberg has retired from the company and Julia Wang has joined this position.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Neuberg Diagnostics secures Rs 940 Cr from Kotak Alt
BioSpectrum Asia

Neuberg Diagnostics secures Rs 940 Cr from Kotak Alt

Neuberg Diagnostics has secured Rs 940 crore from Kotak Alt in the largest-ever primary fund-raise in the Indian diagnostics sector.

time-read
1 min  |
BioSpectrum Asia Feb 2025
RNT Health Insights receives 2nd US FDA BDD for oesophageal cancer detection tool
BioSpectrum Asia

RNT Health Insights receives 2nd US FDA BDD for oesophageal cancer detection tool

RNT Health Insights, an Indian health-tech startup specialising in AI-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, has been granted its second US FDA Breakthrough Device Designation (BDD) for its Oesophageal Cancer detection tool.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Middle East: A rising powerhouse in Medtech and Diagnostics.
BioSpectrum Asia

Middle East: A rising powerhouse in Medtech and Diagnostics.

The Middle East's medtech and diagnostics sector is undergoing a dynamic transformation, fuelled by rapid technological advancements and strategic healthcare investments.

time-read
5 mins  |
BioSpectrum Asia Feb 2025
Alebund Pharmaceuticals announces first closing of RMB 550 M in Series C financing
BioSpectrum Asia

Alebund Pharmaceuticals announces first closing of RMB 550 M in Series C financing

Shanghai-based Alebund Pharmaceuticals, an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions, has announced the closing of RMB 550 million in Series C financing.

time-read
1 min  |
BioSpectrum Asia Feb 2025
IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes
BioSpectrum Asia

IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes

The Indian Institute of Technology, Bombay (IIT-B) has entered into a Memorandum of Understanding (MoU) with Japan's Tohoku University to launch the IIT Bombay-Tohoku University Joint Academic & Research Programme.

time-read
1 min  |
BioSpectrum Asia Feb 2025
Bio-Thera Solutions & Tabuk Pharma to commercialise Stelara biosimilar in Saudi Arabia
BioSpectrum Asia

Bio-Thera Solutions & Tabuk Pharma to commercialise Stelara biosimilar in Saudi Arabia

China-based Bio-Thera Solutions Inc.,

time-read
1 min  |
BioSpectrum Asia Feb 2025

صفحة 1 of 28

12345678910 التالي